TREM2 and Alzheimer disease: To assess whether chronic microelectrode implantation leads to aberrant protein aggregation with aging or in neurodegenerative disease, lipofuscin was assessed over a 12 week implantation period in an 18 month-old AD mouse model (hAbeta/APOE4/Trem2*R47H).